Hi Guest
X   

Real-Time Quote

Enter Company or MF 

Venus Remedies Ltd.

BSE   |   NSE

526953  VENRE  Group (B) BSE data    Add to Watchlist   |  View Tips
    Zoom

How hot is this stock?  © Rediff.com

-40
Price*         
Volume*         
MF holdings         
Sales         
Net profit margin         
  * Computed on last 15 days' trading figures.
Type Numbers Only
Advanced

If you had invested…

Rs ago
You would have
Rs 00,00,00,000.00

* Based on prev close (src - Rediff MoneyWiz)

Report card

AttributeValueDate
PE ratio 3.0723/05/12
EPS (Rs) 52.62Mar, 12
Sales (Rs crore) 114.63Mar, 12
Face Value (Rs)10 
Net profit margin (%) 13.29Mar, 11
Last dividend (%)3026/07/11
Return on average equity19.6Mar, 11

Research centre

Results Statement
Balance sheet - P&L - Cash flow
More
Dividend - Share holding
Capital structures - Ratio

AnnouncementsMore

22 May   Venus Remedies bags another patent grant from South Africa   
04 May   Financial Results and Limited Review for March 31, 2012   
24 Apr   Innovative Solution for alleviating cancer   
10 Apr   Venus Remedies "Vancoplus" gets Patent from Australia   
19 Mar   Venus's ACHNIL, BioSpectrum Product of the Year 2012   
27 Feb   Outcome of Board Meeting   
21 Feb   Board Meeting on Feb 27, 2012   
06 Feb   Venus Remedies to enter Japan market with patent approval for its novel research product 'Vancoplus'   
27 Jan   Financial Results and Limited Review for Dec 31, 2011   
13 Dec 2011   Emerging Company of the year 2011   

Compare with

CompanyPrev close
355.95
539.45
215.00
1,959.65
107.70
944.85
309.20
632.10
419.60
341.30

Add Your Stock Call

    Buy        Sell      
         LTP (Rs.)   Close [x]
Time Period
Target (Rs.)
Stop Loss (Rs.)
    
Thank you. Your call will appear shortly. Your returns will be updated at the end of the trading day. View All Calls

Mutual Fund Selector

Find the fund that is right for you

Create your Portfolio

Track your investments and get daily updates